Norachem is a start-up that specialises in the use of generative design to create small molecule drugs.
While computational approaches have become widespread in drug discovery in the last few years, most of the approaches have proved inadequate to solve the complex problem of creating molecules that satisfy multiple, often conflicting design goals.
Generative design combines deep learning, artificial intelligence, graph theory, computational geometry, and genetic programming to search a near-infinite chemical space and produce molecular structures with optimal values for multiple objectives. The result is the production of better drug molecules faster.
For more information, please contact amit at norachem dot io.
Company Details
- Employees
- 3
- Founded
- -
- Address
- New York, Ny 10034, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://norachem.io/
- Keywords
- drug-design and generative-design.
- HQ
- New York, NY
Norachem Questions
Norachem's website is https://norachem.io/
Norachem's LinkedIn profile is https://www.linkedin.com/company/norachem
Norachem has
3 employees.
View email and phone details for 3
employees at Norachem.
Norachem's industry is
Pharmaceutical Manufacturing
Norachem's top competitors are
Recursion,
Mila Pr,
Quantabricks,
Ignite Foundation,
Alkahest, Inc.,
House Of Misogi Ltd.,
Stealth Mode Biotech,
Reneubio Inc,
Denali Therapeutics,
Neuroage Therapeutics.
Norachem's categories are Pharmaceutical Manufacturing
Norachem's founding year is 2020
